SODIUM CROMOGLICATE PRESERVATIVE FREE eye drops solution
Product Description
Rafarm S.A
-
GR
-
2015On CPHI since
Rafarm S.A
-
GR
-
2015On CPHI since
More Products from Rafarm S.A (38)
-
Product LEVOFLOXACIN PRESERVATIVE FREE eye drops solution
Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen) -
Product OLOPATADINE eye drops solution
Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Allergic Conjunctivitis Innovator: Opatanol (Alcon) -
Product PALONOSETRON solution for injection
Strength: 250 mcg/5ml Presentation: vials, 5 ml Therapeutic area: Acute Nausea & Vomiting Innovator: Aloxi (Helsinn Birex) -
Product PARICALCITOL soft gel capsules
Strength: 1 mcg/cap; 2 mcg/cap; 4 mcg/cap Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott) -
Product PARICALCITOL solution for injection
Strength: 2 mcg/ml; 5 mcg/ml Presentation: ampoules, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml); vials, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml) Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott) -
Product PRAMIPEXOLE tablets
Strength: 0.088 mg/tab; 0.18 mg/tab; 0.35 mg/tab; 0.7 mg/tab Therapeutic area: Idiopathic Parkinson's Disease & Idiopathic restless legs syndrome Innovator: Mirapexin (Boehringer Ingelheim) -
Product TOBRAMYCIN + DEXAMETHASONE eye drops suspension
Strength: (3 mg+1 mg)/ml Presentation: vials, 5 ml Therapeutic area: Intraocular inflammation & ocular surface bacterial contamination Innovator: Tobradex (Alcon-Novartis) -
Product TRAVOPROST + TIMOLOL eye drops solution
Strength: (40 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: DuoTrav (Alcon-Novartis) -
Product TRAVOPROST eye drops solution
Strength: 40 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Travatan (Alcon-Novartis) -
Product ZOLEDRONIC ACID concentrate solution for infusion
Strength: 4 mg/5 ml Presentation: vials, 5 ml Therapeutic area: Skeletal Related Events in Advanced Malignancies & Tumour-Induced Hypercalcaemia Innovator: Zometa (Novartis) -
Product ROSUVASTATIN CALCIUM f.c. tablets
Strength: 5 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Events Innovator: Crestor (AstraZeneca) -
Product TOBRAMYCIN eye drops solution
Strength: 3 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Infections Innovator: Tobrex (Alcon)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance